Video Experimental Relacionado
Updated: Jan 25, 2026
08:56
Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
9.6K
El gambito mitocondrial: Reevaluación de la Antimicina A como agente anticancerígeno multifacético
1Department of Physiology, Medical School, Jeonbuk National University, Jeonju, 54896, Republic of Korea.
European journal of medicinal chemistry
|January 23, 2026
Resumen
La Antimicina A (AMA), un inhibidor de la mitocondria complejo III, muestra potentes efectos anticancerígenos al interrumpir la producción de energía y dirigirse a vías clave de resistencia del cáncer. La investigación explora el desarrollo de análogos de AMA más seguros para uso clínico en la terapia del cáncer dirigida a las mitocondrias.
Área de la Ciencia:
- Metabolismo Mitocondrial
- Terapias contra el Cáncer
- Oncología
Sus antecedentes:
- La malignidad depende en gran medida del metabolismo mitocondrial, lo que convierte a las mitocondrias en un objetivo terapéutico clave.
- La Antimicina A (AMA) es un inhibidor del complejo III mitocondrial con un potencial anticancerígeno significativo.
- Comprender los mecanismos multifacéticos de la AMA es crucial para desarrollar tratamientos novedosos contra el cáncer.
Objetivo del estudio:
- Proporcionar un análisis exhaustivo de la Antimicina A (AMA) como agente anticancerígeno multifacético.
- Explorar los mecanismos canónicos y no canónicos de la AMA contra la resiliencia del cáncer.
- Evaluar estrategias para el desarrollo de análogos de AMA más seguros y clínicamente viables.
Principales métodos:
- Revisión de la literatura sobre los efectos de la Antimicina A en el metabolismo mitocondrial.
- Análisis del impacto de la AMA en la fosforilación oxidativa (OXPHOS), los niveles de ATP, la producción de ROS y la apoptosis.
- Investigación de las funciones no canónicas de la AMA, incluida la actividad mimética de BH3, la degradación de c-Myc y la inhibición de la señalización Wnt/β-catenina.
Principales resultados:
- La AMA interrumpe el OXPHOS, lo que lleva a la depleción de ATP, oleadas de ROS y apoptosis.
- La AMA inhibe el Bcl-xL y promueve la degradación de c-Myc mediada por ROS.
- La AMA se dirige a células madre cancerosas (CSC) quimiorresistentes al suprimir la señalización Wnt/β-catenina.
Conclusiones:
- La Antimicina A exhibe potentes actividades antineoplásicas a través de diversos mecanismos.
- La toxicidad sistémica de la AMA presenta limitaciones farmacológicas.
- La AMA sirve como compuesto líder para el desarrollo de nuevas terapias contra el cáncer dirigidas a las mitocondrias.
Videos de Conceptos Relacionados
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
521
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
521
02:59Animal Mitochondrial Genetics
9.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.0K
02:16Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
15.5K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
15.5K
02:19Export of Mitochondrial and Chloroplast Genes
4.1K
A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.1K
01:29Subviral Agents
550
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
550
01:28The Inner Mitochondrial Membrane
4.6K
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
4.6K